The latest stem cell-based anti-aging and cosmetic therapies available, eliminating the need for invasive surgery.
Miami (PRWEB) March 10, 2014
Regenestem, Inc., a division of Global Stem Cells Group, has announced plans to build the first Regenestem brand clinic in the Philippines. The planned, 22,000 square foot, state-of-the-art medical facility in Manila will focus on providing the latest stem cell-based anti-aging and cosmetic therapies available, eliminating the need for invasive surgery.
Regenestem is collaborating with distinguished Philippine Cosmetic Surgeon Eric Yalung, M.D. of the Cosmetic Surgery Institute-Manila, Inc. to create the stem cell therapy center, offering the most advanced protocols in cosmetic cellular medicine to patients from around the world.
The new Regenestem clinic will be headed by Yalung, a prominent and popular cosmetic surgeon in Manila who has built a reputation for incorporating the latest, most modern and least-invasive techniques in aesthetic medicine into his practice. Yalung will be joined by a team of talented stem cell specialists to provide patient treatment and follow-up care under the Regenestem brand.
Regenestem currently offers stem cell treatments for arthritis, autism, chronic obstructive pulmonary disease (COPD), diabetes and multiple sclerosis among other conditions at various facilities worldwide
As part of its commitment to maintaining the highest standards in service and technology, Regenestem provides an international staff and the leading cellular therapies available.
All Regenestem facilities are certified for the medical tourism market, and staff physicians are board-certified or board-eligible. Regenestem clinics provide services in more than 10 specialties, attracting patients from the United States and around the world.
For more information, visit the Regenestem website, email info(at)regenstem(dot)com, or call 305-224-1858.
Regenestem, a division of the Global Stem Cells Group, Inc., is an international medical practice association committed to researching and producing comprehensive stem cell treatments for patients worldwide. Having assembled a highly qualified staff of medical specialists—professionals trained in the latest cutting-edge techniques in cellular medicine—Regenestem continues to be a leader in delivering the latest protocols in the adult stem cell arena.
About the Global Stem Cell Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
To learn more about Global Stem Cells Group, Inc.’s companies, and for investor information, visit the Global Stem Cell Group website, email bnovas(at)regenestem(dot)com, or call 305-224-1858.